Veritable’s UnitedHealth UNH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-27,455
| Closed | -$13.2M | – | 751 |
|
|
2023
Q2 | $13.2M | Sell |
27,455
-108
| -0.4% | -$52.8K | 0.2% | 55 |
|
|
2023
Q1 | $13M | Buy |
27,563
+748
| +3% | +$361K | 0.21% | 54 |
|
|
2022
Q4 | $14.2M | Buy |
26,815
+477
| +2% | +$253K | 0.24% | 49 |
|
|
2022
Q3 | $13.3M | Sell |
26,338
-6,729
| -20% | -$3.54M | 0.26% | 45 |
|
|
2022
Q2 | $17M | Buy |
33,067
+106
| +0.3% | +$53.2K | 0.31% | 39 |
|
|
2022
Q1 | $16.8M | Sell |
32,961
-374
| -1% | -$180K | 0.26% | 45 |
|
|
2021
Q4 | $16.7M | Sell |
33,335
-216
| -0.6% | -$97.8K | 0.25% | 51 |
|
|
2021
Q3 | $13.1M | Sell |
33,551
-270
| -0.8% | -$112K | 0.21% | 56 |
|
|
2021
Q2 | $13.5M | Buy |
33,821
+249
| +0.7% | +$99.3K | 0.22% | 57 |
|
|
2021
Q1 | $12.5M | Buy |
33,572
+121
| +0.4% | +$41.9K | 0.21% | 57 |
|
|
2020
Q4 | $11.7M | Sell |
33,451
-4,300
| -11% | -$1.44M | 0.22% | 59 |
|
|
2020
Q3 | $11.8M | Buy |
37,751
+103
| +0.3% | +$31.6K | 0.24% | 53 |
|
|
2020
Q2 | $11.1M | Sell |
37,648
-2,372
| -6% | -$680K | 0.24% | 58 |
|
|
2020
Q1 | $9.98M | Sell |
40,020
-3,376
| -8% | -$929K | 0.24% | 57 |
|
|
2019
Q4 | $12.8M | Buy |
43,396
+447
| +1% | +$117K | 0.23% | 60 |
|
|
2019
Q3 | $9.33M | Buy |
42,949
+760
| +2% | +$183K | 0.18% | 76 |
|
|
2019
Q2 | $10.3M | Buy |
42,189
+1,388
| +3% | +$334K | 0.2% | 71 |
|
|
2019
Q1 | $10.1M | Buy |
40,801
+432
| +1% | +$110K | 0.2% | 73 |
|
|
2018
Q4 | $10.1M | Sell |
40,369
-260
| -0.6% | -$68.7K | 0.23% | 64 |
|
|
2018
Q3 | $10.8M | Buy |
40,629
+695
| +2% | +$181K | 0.22% | 69 |
|
|
2018
Q2 | $9.8M | Sell |
39,934
-290
| -0.7% | -$69.6K | 0.21% | 69 |
|
|
2018
Q1 | $8.61M | Buy |
40,224
+1,133
| +3% | +$259K | 0.19% | 76 |
|
|
2017
Q4 | $8.62M | Sell |
39,091
-2,638
| -6% | -$559K | 0.17% | 81 |
|
|
2017
Q3 | $8.17M | Sell |
41,729
-283
| -0.7% | -$54.7K | 0.17% | 89 |
|
|
2017
Q2 | $7.79M | Buy |
42,012
+6,454
| +18% | +$1.13M | 0.18% | 88 |
|
|
2017
Q1 | $5.83M | Sell |
35,558
-557
| -2% | -$91.2K | 0.14% | 103 |
|
|
2016
Q4 | $5.78M | Sell |
36,115
-2,112
| -6% | -$315K | 0.14% | 97 |
|
|
2016
Q3 | $5.35M | Buy |
38,227
+2,361
| +7% | +$331K | 0.13% | 108 |
|
|
2016
Q2 | $5.06M | Buy |
35,866
+1,061
| +3% | +$141K | 0.13% | 108 |
|
|
2016
Q1 | $4.49M | Sell |
34,805
-10,312
| -23% | -$1.22M | 0.12% | 115 |
|
|
2015
Q4 | $5.31M | Sell |
45,117
-959
| -2% | -$112K | 0.15% | 102 |
|
|
2015
Q3 | $5.34M | Sell |
46,076
-259
| -0.6% | -$31K | 0.16% | 94 |
|
|
2015
Q2 | $5.65M | Sell |
46,335
-13,207
| -22% | -$1.56M | 0.15% | 101 |
|
|
2015
Q1 | $7.04M | Sell |
59,542
-792
| -1% | -$88K | 0.15% | 116 |
|
|
2014
Q4 | $6.1M | Sell |
60,334
-1,698
| -3% | -$161K | 0.13% | 133 |
|
|
2014
Q3 | $5.35M | Sell |
62,032
-484
| -0.8% | -$40.9K | 0.11% | 137 |
|
|
2014
Q2 | $5.11M | Sell |
62,516
-3,919
| -6% | -$308K | 0.11% | 140 |
|
|
2014
Q1 | $5.45M | Sell |
66,435
-968
| -1% | -$72.9K | 0.12% | 134 |
|
|
2013
Q4 | $5.08M | Buy |
67,403
+1,860
| +3% | +$134K | 0.11% | 138 |
|
|
2013
Q3 | $4.69M | Buy |
65,543
+8,934
| +16% | +$639K | 0.11% | 142 |
|
|
2013
Q2 | $3.71M | Buy |
+56,609
| New | +$3.52M | 0.09% | 160 |
|
Other funds holding UNH
Veritable's UNH Position: Q3 2023 in Review
Veritable sold out of UnitedHealth (UNH) in Q3 2023, closing a stake of 27,455 shares — an estimated $13.2M sold.
Veritable first reported a position in UNH in Q2 2013 and held it in 41 quarters. The position peaked at $17M in Q2 2022. 3,137 funds tracked by Wall St. Rank hold UNH as of Q3 2023.
- Veritable reported no remaining UnitedHealth position as of Q3 2023 after selling out during the quarter.
- Veritable sold 27,455 UnitedHealth shares in Q3 2023, an estimated $13.2M.
- Veritable first reported a position in UnitedHealth in Q2 2013 and held it in 41 quarters.
- Veritable's UnitedHealth position peaked at $17M in Q2 2022.
- 3,137 funds tracked by Wall St. Rank held UnitedHealth as of Q3 2023.
Based on Veritable's 13F filing for Q3 2023.